<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1089</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11188697</PubmedId>
            <Abstract>BACKGROUND: The gp120 exterior envelope glycoprotein of HIV-1 binds sequentially to CD4 and chemokine receptors on cells to initiate virus entry. During natural infection, gp120 is a primary target of the humoral immune response, and it has evolved to resist antibody-mediated neutralization. We previously reported the structure at 2.5 A of a gp120 core from the HXBc2 laboratory-adapted isolate in complex with a 2 domain fragment of CD4 and the antigen binding fragment of a human antibody. This revealed atomic details of gp120-receptor interactions and suggested multiple mechanisms of immune evasion. RESULTS: The gp120 exterior envelope glycoprotein of HIV-1 binds sequentially to CD4 and chemokine receptors on cells to initiate virus entry. During natural infection, gp120 is a primary target of the humoral immune response, and it has evolved to resist antibody-mediated neutralization. We previously reported the structure at 2.5 A of a gp120 core from the HXBc2 laboratory-adapted isolate in complex with a 2 domain fragment of CD4 and the antigen binding fragment of a human antibody. This revealed atomic details of gp120-receptor interactions and suggested multiple mechanisms of immune evasion.We have now extended the HXBc2 structure in P222, crystals to 2.2 A. The enhanced resolution enabled a more accurate modeling of less-well-ordered regions and provided conclusive identification of the density in the central cavity at the crux of the gp120-CD4 interaction as isopropanol from the crystallization medium. We have also determined the structure of a gp120 core from the primary clinical HIV-1 isolate, YU2, in the same ternary complex but in a C2 crystal lattice. Comparisons of HXBc2 and YU2 showed that while CD4 binding was rigid, portions of the gp120 core were conformationally flexible; overall differences were minor, with sequence changes concentrated on a surface expected to be exposed on the envelope oligomer. CONCLUSIONS: The gp120 exterior envelope glycoprotein of HIV-1 binds sequentially to CD4 and chemokine receptors on cells to initiate virus entry. During natural infection, gp120 is a primary target of the humoral immune response, and it has evolved to resist antibody-mediated neutralization. We previously reported the structure at 2.5 A of a gp120 core from the HXBc2 laboratory-adapted isolate in complex with a 2 domain fragment of CD4 and the antigen binding fragment of a human antibody. This revealed atomic details of gp120-receptor interactions and suggested multiple mechanisms of immune evasion.We have now extended the HXBc2 structure in P222, crystals to 2.2 A. The enhanced resolution enabled a more accurate modeling of less-well-ordered regions and provided conclusive identification of the density in the central cavity at the crux of the gp120-CD4 interaction as isopropanol from the crystallization medium. We have also determined the structure of a gp120 core from the primary clinical HIV-1 isolate, YU2, in the same ternary complex but in a C2 crystal lattice. Comparisons of HXBc2 and YU2 showed that while CD4 binding was rigid, portions of the gp120 core were conformationally flexible; overall differences were minor, with sequence changes concentrated on a surface expected to be exposed on the envelope oligomer.Despite dramatic antigenic differences between primary and laboratory-adapted HIV-1, the gp120 cores from these isolates are remarkably similar. Taken together with chimeric substitution and sequence analysis, this indicates that neutralization resistance is specified by quaternary interactions involving the major variable loops and thus affords a mechanism for viral adaptation. Conservation of the central cavity suggests the possibility of therapeutic inhibitors. The structures reported here extend in detail and generality our understanding of the biology of the gp120 envelope glycoprotein.</Abstract>
            <ArticleYear>2000</ArticleYear>
            <ArticlePages>1329-39</ArticlePages>
            <ArticleTitle>Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kwong</LastName>
                    <ForeName>P D</ForeName>
                </Author>
                <Author>
                    <LastName>Wyatt</LastName>
                    <ForeName>R</ForeName>
                </Author>
                <Author>
                    <LastName>Majeed</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Robinson</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Sweet</LastName>
                    <ForeName>R W</ForeName>
                </Author>
                <Author>
                    <LastName>Sodroski</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Hendrickson</LastName>
                    <ForeName>W A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York 10032, USA.</Affiliations>
            <ArticleChemicalList>HIV Envelope Protein gp120;Receptors, HIV</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Computer Simulation; Crystallization; Crystallography, X-Ray; HIV Envelope Protein gp120(chemistry; metabolism); HIV-1(chemistry; isolation &amp; purification; metabolism; pathogenicity); Humans; Models, Molecular; Molecular Sequence Data; Protein Structure, Tertiary; Receptors, HIV(chemistry; metabolism)</ArticleMeshHeadingsList>
            <Comments>ErratumIn(Structure Fold Des 2001 Feb 7;9(2):following R32 )</Comments>
            <Journal>
                <Volume>8</Volume>
                <Issue>12</Issue>
                <Title>Structure (London, England : 1993)</Title>
                <Issn>1878-4186</Issn>
                <MedlineTa>Structure</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Epitope of 17b Fab on HIV gp120</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>C118, V119, L121, V196, T198, Q199, R406, K408, Q409, I410, M421, P424</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P35961.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>362651</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>PDB 1G9N</LocationOfData>
                <EpitopeId>164069</EpitopeId>
                <ReferenceRegion>C119, V120, L122, V200, T202, Q203, R419, K421, Q422, I423, M434, P437</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope residues are calculated from the PDB structure [PDB: 1G9N] as the antigen residues at 4 Ã… distance from the antibody.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, 4 and 5, Tables 1, 2, 3 and PDB 1G9N</LocationOfData>
                        <BCellId>1846595</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:526</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The monoclonal antibody was made from an HIV infected individual as described in the cited reference: Kwong et al. (1998) Nature 393(6686): 648-659 [PMID: 9641677]. The details were not provided in the reference.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.9</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope for the monoclonal Fab was determined by the crystal structure of the Fab with gp120 core and two-domain CD4 (d1d2). The GP120 core protein had Gly-Ala-Gly tri-peptide substitutions for the V1/V2 and V3 loop regions.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>17b</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>17b</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1G9N_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1G9N_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>HIV YU2 gp120 core</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EVKLENVTENFNMWKNNMVEQMHEDIISLWDQSLKPCVKLTPLCVTLNCTDLRNATNTTSSSWETMEKGEIKNCSFNITTSIRDKVQKEYALFYNLDVVPIDNASYRLISCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNDKKFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEEIVIRSENFTNNAKTIIVQLNESVVINCTRPNNNTRKSINIGPGRALYTTGEIIGDIRQAHCNLSKTQWENTLEQIAIKLKEQFGNNKTIIFNPSSGGDPEIVTHSFNCGGEFFYCNSTQLFTWNDTRKLNNTGRNITLPCRIKQIINMWQEVGKAMYAPPIRGQIRCSSNITGLLLTRDGGKDTNGTEIFRPGGGDMRDNWRSELYKYKVVKIE</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>479</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P35961.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>362651</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideSequence>KKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSK...</PeptideSequence>
                                    <PeptideModifications/>
                                    <PeptideSourceMolecule>
                                        <GenBankId>P01730.1</GenBankId>
                                    </PeptideSourceMolecule>
                                    <PeptideSourceOrganismId>9606</PeptideSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1G9N</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>G</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>G: ;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>G: C119, V120, L122, V200, T202, Q203, R419, K421, Q422, I423, M434, P437</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: I52, L55, V57, H59, E103, E106, G107, E108, Y109, R110; L: W94, P95</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>597.6</ContactAreaForAntigen>
                                <ContactAreaForAntibody>601.7</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Epitope of 17b Fab on HIV gp120</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>C119, V120, L122, V200, T202, Q203, R419, K421, Q422, I423, M434, P437</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P04578.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11706</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>PDB 1G9M</LocationOfData>
                <EpitopeId>164077</EpitopeId>
                <ReferenceRegion>C119, V120, L122, V200, T202, Q203, R419, K421, Q422, I423, M434, P437</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope residues are calculated from the PDB structure [PDB: 1G9M] as the antigen residues at 4 Ã… distance from the antibody.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, 4 and 5, Tables 1, 2, 3 and PDB 1G9M</LocationOfData>
                        <BCellId>1859610</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:526</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The monoclonal antibody was made from an HIV infected individual as described in the cited reference: Kwong et al. (1998) Nature 393(6686): 648-659 [PMID: 9641677]. The details were not provided in the reference.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.2</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope for the monoclonal Fab was determined by the crystal structure of the Fab with gp120 core and two-domain CD4 (d1d2). The GP120 core protein had Gly-Ala-Gly tri-peptide substitutions for the V1/V2 and V3 loop regions.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>17b</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>17b</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1G9N_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1G9N_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>HIV HXBc2 gp120 core</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EVVLVNVTENFNMWKNDMVEQMHEDIISLWDQSLKPCVKLTPLCVSLKCTDLKNDTNTNSSSGRMIMEKGEIKNCSFNISTSIRGKVQKEYAFFYKLDIIPIDNDTTSYKLTSCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVIRSVNFTDNAKTIIVQLNTSVEINCTRPNNNTRKRIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNNTLKQIASKLREQFGNNKTIIFKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWFNSTWSTEGSNNTEGSDTITLPCRIKQIINMWQKVGKAMYAPPISGQIRCSSNITGLLLTRDGGNSNNESEIFRPGGGDMRDNWRSELYKYKVVKIE</LinearSequence>
                                        <StartingPosition>83</StartingPosition>
                                        <EndingPosition>492</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04578.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11706</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideSequence>KKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSK...</PeptideSequence>
                                    <PeptideModifications/>
                                    <PeptideSourceMolecule>
                                        <GenBankId>P01730.1</GenBankId>
                                    </PeptideSourceMolecule>
                                    <PeptideSourceOrganismId>9606</PeptideSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1G9M</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>G</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>G: ;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>G: C119, V120, L122, V200, T202, Q203, R419, K421, Q422, I423, M434, P437</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: I52, L55, V57, H59, E103, E106, G107, E108, Y109, R110, N111; L: W94, P95</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>598.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>582.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

